SEC Form 4 · accession 0001209191-18-026136
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pat Cotroneo
Officer — VP, Finance and CFO
Period of report
Apr 23, 2018
Accepted (ET)
Apr 25, 2018 · 6:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 23, 2018 | M | 33,550 | $2.90 | A | 229,884 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.90 | Apr 23, 2018 | M | 1,550 | D | — | Jun 23, 2020 | Common Stock | 1,550 | 0 | D |
| Stock Option (Right to Buy)F1 | $2.90 | Apr 23, 2018 | M | 32,000 | D | — | Jun 23, 2020 | Common Stock | 32,000 | 0 | D |
Explanation of responses
- F1Fully vested.